Q. I developed severe depression while taking Repatha, the injectable cholesterol lowering drug. It took me a horrible nine months to realize the drug was making me suicidal. If I wasn’t sleeping, I ...
Amgen Inc. ends 2025 on a high note. Thanks to strong sales of Repatha and Imdelltra, it raised its full-year 2025 revenue guidance from $35-$36 billion to $35.8-$36.6 billion. So, sales of Repatha, a ...
Q. I developed severe depression while taking Repatha, the injectable cholesterol-lowering drug. It took me a horrible nine months to realize the drug was making me suicidal. If I wasn’t sleeping, I ...
MSD has fleshed out the results of phase 3 trials of its cholesterol-lowering, oral PCSK9 inhibitor, enlicitide decanoate, showing its efficacy was comparable to that of injectable alternatives. The ...
President Donald Trump announced Friday the latest reduced drug pricing deal made with a group of large pharmaceutical companies including Amgen, Gilead and Merck, doing so about four months after the ...
Editor's note: This article was updated at 320p ET to reflect a news conference at the White House with President Trump formally announcing the deals and providing additional details. The companies ...
Nine more pharma groups have agreed to lower the costs of their medicines in the US under the Trump administration's most favoured nation (MFN) scheme in return for avoiding tariffs. US companies ...
Dec 19 (Reuters) - The U.S. Food and Drug Administration said on Friday it has granted national priority vouchers to Merck's (MRK.N), opens new tab cholesterol pill and its cancer therapy, making them ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback